Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
J Drugs Dermatol ; 22(1): 29-34, 2023 Jan 01.
Article in English | MEDLINE | ID: mdl-36607760

ABSTRACT

The treatment of primary scarring alopecias is challenging and patients may be susceptible to koebnerization. This predisposes cicatricial alopecia patients to worsening of their disease following procedural treatments or interventions. Research and recommendations surrounding the risk for koebnerization within scarring alopecias is extremely limited. Using a comprehensive literature review, we summarized the risks of procedures in potentially koebnerizing alopecias. We evaluated the risk not only with procedural treatments, but also with common elective cosmetic procedures and potentially trauma-inducing hairstyling techniques. Although additional studies are needed to better elucidate the risks of procedural treatments within primary scarring alopecia, we believe this review of the current evidence and expert insight will benefit healthcare providers and patients alike to help guide treatments in this challenging patient population. J Drugs Dermatol. 2023;22(1):29-34. doi:10.36849/JDD.6849.


Subject(s)
Alopecia , Cicatrix , Humans , Cicatrix/diagnosis , Cicatrix/etiology , Cicatrix/therapy , Alopecia/diagnosis , Alopecia/etiology , Alopecia/drug therapy , Health Personnel
2.
J Am Acad Dermatol ; 83(4): 996-1004, 2020 Oct.
Article in English | MEDLINE | ID: mdl-32360759

ABSTRACT

The growth of molecular technologies analyzing skin cells and inherited genetic variations has the potential to address current gaps in both diagnostic accuracy and prognostication in patients with melanoma or in individuals who are at risk for developing melanoma. In the second article in this continuing medical education series, novel molecular technologies are reviewed. These have been developed as adjunct tools for melanoma management and include the Pigmented Lesion Assay, myPath Melanoma, and DecisionDx-Melanoma tests, and genetic testing in patients with a strong familial melanoma history. These tests are commercially available and marketed as ancillary tools for clinical decision-making, diagnosis, and prognosis. We review fundamental principles behind each test, discuss peer-reviewed literature assessing their performance, and highlight the utility and limitations of each assay. The goal of this article is to provide a comprehensive, evidence-based foundation for clinicians regarding the management of patients with difficult pigmented lesions.


Subject(s)
Gene Expression Profiling , Genetic Testing , Melanoma/diagnosis , Melanoma/genetics , Pancreatic Neoplasms/genetics , Skin Neoplasms/diagnosis , Skin Neoplasms/genetics , Antigens, Neoplasm/genetics , Cyclin-Dependent Kinase Inhibitor p16/genetics , Gene Expression Profiling/methods , Humans , Molecular Diagnostic Techniques , RNA, Long Noncoding/genetics
3.
J Am Acad Dermatol ; 83(4): 983-992, 2020 Oct.
Article in English | MEDLINE | ID: mdl-32348823

ABSTRACT

Managing the balance between accurately identifying early stage melanomas while avoiding obtaining biopsy specimens of benign lesions (ie, overbiopsy) is the major challenge of melanoma detection. Decision making can be especially difficult in patients with extensive atypical nevi. Recognizing that the primary screening modality for melanoma is subjective examination, studies have shown a tendency toward overbiopsy. Even low-risk routine surgical procedures are associated with morbidity, mounting health care costs, and patient anxiety. Recent advancements in noninvasive diagnostic modalities have helped improve diagnostic accuracy, especially when managing melanocytic lesions of uncertain diagnosis. Breakthroughs in artificial intelligence have also shown exciting potential in changing the landscape of melanoma detection. In the first article in this continuing medical education series, we review novel diagnostic technologies, such as automated 2- and 3-dimensional total body imaging with sequential digital dermoscopic imaging, reflectance confocal microscopy, and electrical impedance spectroscopy, and we explore the logistics and implications of potentially integrating artificial intelligence into existing melanoma management paradigms.


Subject(s)
Machine Learning , Melanoma/diagnostic imaging , Photography/methods , Skin Neoplasms/diagnostic imaging , Biomedical Technology , Dermoscopy/methods , Dielectric Spectroscopy , Humans , Imaging, Three-Dimensional , Microscopy, Confocal/methods
4.
Int J Dermatol ; 61(5): 519-531, 2022 May.
Article in English | MEDLINE | ID: mdl-33951189

ABSTRACT

B-cell chronic lymphocytic leukemia (CLL) is the most prevalent leukemia in the United States, and its diagnosis can have many dermatologic implications. For one, the cutaneous manifestations of CLL include several entities, most notably leukemia cutis, eosinophilic dermatosis of hematologic malignancy, and a heightened risk of skin infections. Additionally, CLL patients are at an increased risk of secondary malignancies, most commonly of the skin. Furthermore, a number of commonly utilized treatments for CLL have cutaneous implications which should be considered in the interdisciplinary management of CLL patients. In this review, we will provide an update on the diverse cutaneous manifestations of CLL and CLL-directed therapies in order to help guide dermatologic management of this increasingly prevalent patient population.


Subject(s)
Leukemia, Lymphocytic, Chronic, B-Cell , Skin Diseases , Skin Neoplasms , Dermatologists , Humans , Leukemia, Lymphocytic, Chronic, B-Cell/complications , Leukemia, Lymphocytic, Chronic, B-Cell/diagnosis , Leukemia, Lymphocytic, Chronic, B-Cell/pathology , Skin/pathology , Skin Diseases/diagnosis , Skin Diseases/etiology , Skin Diseases/therapy , Skin Neoplasms/diagnosis , Skin Neoplasms/etiology , Skin Neoplasms/therapy , United States
5.
Am J Clin Dermatol ; 22(5): 681-692, 2021 Sep.
Article in English | MEDLINE | ID: mdl-34347282

ABSTRACT

Lichen planopilaris is a primary lymphocytic cicatricial alopecia that commonly presents with hair loss at the vertex or parietal scalp. Patients may also have associated scalp itching, burning or tenderness. Due to scarring, hair loss is typically permanent. The main goals of treatment are reducing symptoms and preventing disease progression and further hair loss. Currently, the literature has limited evidence on treatments for this difficult condition, and most available evidence is from case reports and case series. Furthermore, the evidence shows a varied response to therapy, with frequent reports of poor response. This article reviews the diagnosis of this rare disease, summarize the currently available treatments, and provide insights and practices from alopecia experts.


Subject(s)
Lichen Planus/diagnosis , Lichen Planus/therapy , Scalp Dermatoses/diagnosis , Scalp Dermatoses/therapy , Humans , Scalp/pathology , Scalp Dermatoses/pathology
6.
JAMA Dermatol ; 157(2): 189-197, 2021 02 01.
Article in English | MEDLINE | ID: mdl-33404623

ABSTRACT

Importance: Dermoscopy education in US dermatology residency programs varies widely, and there is currently no existing expert consensus identifying what is most important for resident physicians to know. Objectives: To identify consensus-based learning constructs representing an appropriate foundational proficiency in dermoscopic image interpretation for dermatology resident physicians, including dermoscopic diagnoses, associated features, and representative teaching images. Defining these foundational proficiency learning constructs will facilitate further skill development in dermoscopic image interpretation to help residents achieve clinical proficiency. Design, Setting, and Participants: A 2-phase modified Delphi surveying technique was used to identify resident learning constructs in 3 sequential sets of surveys-diagnoses, features, and images. Expert panelists were recruited through an email distributed to the 32 members of the Pigmented Lesion Subcommittee of the Melanoma Prevention Working Group. Twenty-six (81%) opted to participate. Surveys were distributed using RedCAP software. Main Outcomes and Measures: Consensus on diagnoses, associated dermoscopic features, and representative teaching images reflective of a foundational proficiency in dermoscopic image interpretation for US dermatology resident physicians. Results: Twenty-six pigmented lesion and dermoscopy specialists completed 8 rounds of surveys, with 100% (26/26) response rate in all rounds. A final list of 32 diagnoses and 116 associated dermoscopic features was generated. Three hundred seventy-eight representative teaching images reached consensus with panelists. Conclusions and Relevance: Consensus achieved in this modified Delphi process identified common dermoscopic diagnoses, associated features, and representative teaching images reflective of a foundational proficiency in dermoscopic image interpretation for dermatology residency training. This list of validated objectives provides a consensus-based foundation of key learning points in dermoscopy to help resident physicians achieve clinical proficiency in dermoscopic image interpretation.


Subject(s)
Dermatologists/standards , Dermatology/methods , Dermoscopy/standards , Internship and Residency/standards , Clinical Competence , Delphi Technique , Dermatologists/education , Dermatology/education , Dermatology/standards , Dermoscopy/education , Humans , Skin Diseases/diagnosis , Surveys and Questionnaires
SELECTION OF CITATIONS
SEARCH DETAIL